NuCana (NCNA) vs Pulmatrix (PULM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pulmatrix is the larger company by market cap ($5.2 million vs $4.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | NCNA | PULM |
|---|---|---|
| Share price | $1.12 | $1.44 |
| Market cap | $4.67M | $5.25M |
| 1-day change | -1.67% | -3.56% |
| EPS (TTM) | $0.00 | $-1.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.40 | $5.24 |
| 52-week low | $0.948 | $1.16 |
| Distance from 52-week high | -82.48% | -72.55% |
| Average volume | 123.99K | 24.75K |
| Shares outstanding | 4.16M | 3.65M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
NCNA vs PULM FAQ
Which is bigger, NuCana or Pulmatrix?
Pulmatrix (PULM) is larger, with a market capitalization of $5.25M compared with $4.67M for NuCana (NCNA).
Are NuCana and Pulmatrix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.